ORAI3 and neoplasm: The colony-forming ability and cell migration capacity of tumor cells were impaired after treatment with siHIF-1α and siHIF-2α, as well as siOrai3, thus indicating that HIF-1/2α promote Orai3 up-regulation, which, in turn, supports colon cancer progression [55].